| Dr Evan James Cretney, MD | |
|
2414 Kohler Memorial Drive, Sheboygan, WI 53081 | |
| (920) 457-4461 | |
| Not Available |
| Full Name | Dr Evan James Cretney |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 2414 Kohler Memorial Drive, Sheboygan, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528563442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MT216241 (Pennsylvania) | Secondary |
| 207Y00000X | Otolaryngology | 81319 (Wisconsin) | Primary |
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The Toy Industry Foundation, the philanthropic arm of the North American toy industry, and Nemours, one of the country's largest pediatric health systems, operating two children's hospitals and more than 40 outpatient facilities with operations in five states, today announced the launch of a year-long research partnership.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
The United States-Mexico Border Field Office of the Pan American Health Organization and the U.S.-Mexico Border Health Association are beginning a new stage of cooperation.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the Cancer and Metabolism: Pathways to the Future meeting in Edinburgh, Scotland, as well as two additional posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics" November 16-19, 2010, in Berlin, Germany.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evan James Cretney, MD 2414 Kohler Memorial Drive, Sheboygan, WI 53081 Ph: (920) 400-9665 | Dr Evan James Cretney, MD 2414 Kohler Memorial Drive, Sheboygan, WI 53081 Ph: (920) 457-4461 |
News Archive
The Toy Industry Foundation, the philanthropic arm of the North American toy industry, and Nemours, one of the country's largest pediatric health systems, operating two children's hospitals and more than 40 outpatient facilities with operations in five states, today announced the launch of a year-long research partnership.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
The United States-Mexico Border Field Office of the Pan American Health Organization and the U.S.-Mexico Border Health Association are beginning a new stage of cooperation.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the Cancer and Metabolism: Pathways to the Future meeting in Edinburgh, Scotland, as well as two additional posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics" November 16-19, 2010, in Berlin, Germany.
› Verified 5 days ago
Dr. John Revelis, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2414 Kohler Memorial Dr, Sheboygan, WI 53081 Phone: 920-457-4461 Fax: 920-459-1152 | |
P Perry Phillips, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2629 N 7th St, Sheboygan, WI 53083 Phone: 920-451-5000 | |
Dr. Edward Lawrence Smith, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1411 N Taylor Dr, Sheboygan, WI 53081 Phone: 616-735-3257 |